Related Experiment Videos
Hypothyroidism leads to increased dopamine receptor sensitivity and concentration
Pharmacology, Biochemistry, and Behavior
|June 1, 1986
Summary
Hypothyroidism in rats increased dopamine receptor sensitivity, evidenced by heightened responses to apomorphine and altered reactions to haloperidol. This suggests thyroid hormones influence dopamine system regulation.
Area of Science:
- Neuroendocrinology
- Pharmacology
- Thyroid Research
Background:
- Thyroid hormones play a crucial role in regulating various physiological processes, including central nervous system function.
- Dopamine pathways are implicated in motor control, reward, and hormone regulation, and their function can be modulated by thyroid status.
Purpose of the Study:
- To investigate the impact of experimentally induced hypothyroidism on dopamine receptor sensitivity in rats.
- To explore the relationship between thyroid hormone levels and the expression and function of dopamine receptors.
Main Methods:
- Rats were rendered hypothyroid using iodine-131 treatment, confirmed by physiological and hormonal markers.
- Behavioral assessments included responses to apomorphine (stereotypy, operant responding, body temperature) and haloperidol (locomotor activity).
- Dopamine D2 receptor concentrations and affinities were measured in striatal homogenates using receptor binding assays.
Main Results:
- Hypothyroid rats exhibited increased sensitivity to apomorphine, showing exaggerated effects on stereotypy, operant responding, and body temperature.
- Locomotor activity reduction was less pronounced in hypothyroid rats following haloperidol administration.
- Receptor binding studies revealed a significant increase in D2 dopamine receptor concentrations in hypothyroid rats, without alterations in receptor affinity.
Conclusions:
- Hypothyroidism enhances dopamine receptor sensitivity in rats, primarily through an increase in D2 dopamine receptor concentration.
- These findings highlight the significant influence of thyroid status on dopaminergic neurotransmission and receptor regulation.